McNeill Jonathan

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 1% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McNeill Jonathan's trades of Crescent Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
182.34
Quantity 97,918
Value US$1,970,682
Transaction date
Planned sale
Price
190.14
Quantity 23,826 -33.8%
Value US$3,964,547
Transaction date
Proposed sale
Price
29.69
Quantity 19,987
Value US$593,414
Transaction date
Proposed sale
Price
28.39
Quantity 2,658
Value US$75,460
Transaction date
Proposed sale
Price
34.51
Quantity 1,870
Value US$64,528
Transaction date
Proposed sale
Price
32.43
Quantity 1,823
Value US$59,120
Transaction date
Proposed sale
Price
33.61
Quantity 166,767
Value US$5,605,442
Transaction date
Proposed sale
Price
45.12
Quantity 2,705
Value US$122,043
Transaction date
Proposed sale
Price
31.50
Quantity 1,823
Value US$57,424
Transaction date
Proposed sale
Price
28.70
Quantity 2,774
Value US$79,613
Transaction date
Proposed sale
Price
25.16
Quantity 19,601
Value US$493,161
Transaction date
Proposed sale
Price
2.64
Quantity 90,000
Value US$237,996
Transaction date
Planned sale
Price
24.52
Quantity 19,822 -12.1%
Value US$486,035
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-18
PrS Proposed sale
97,918
182.34
US$1,970,682 		97,918 182.34 US$1,970,682
2026-09-16 2026-09-16
PrS Proposed sale
22,328
371.33
US$3,523,839 		22,328 371.33 US$3,523,839
2026-06-23 2026-06-22
PlS Planned sale
23,826 -33.8%
190.14
US$3,964,547 		23,826 -33.8% 190.14 US$3,964,547
2024-11-25 2024-11-25
PrS Proposed sale
19,987
29.69
US$593,414 		19,987 29.69 US$593,414
2024-11-18 2024-11-18
PrS Proposed sale
2,658
28.39
US$75,460 		2,658 28.39 US$75,460
2024-09-18 2024-09-18
PrS Proposed sale
1,870
34.51
US$64,528 		1,870 34.51 US$64,528
2024-09-11 2024-09-11
PrS Proposed sale
1,823
32.43
US$59,120 		1,823 32.43 US$59,120
2024-09-05 2024-09-05
PrS Proposed sale
166,767
33.61
US$5,605,442 		166,767 33.61 US$5,605,442
2024-08-20 2024-08-19
PlS Planned sale
305 -0.2%
46.00
US$14,030 		305 -0.2% 46.00 US$14,030
2024-08-20 2024-08-19
PlS Planned sale
2,400 -1.8%
45.01
US$108,024 		2,400 -1.8% 45.01 US$108,024
2024-08-19 2024-08-19
PrS Proposed sale
2,705
45.12
US$122,043 		2,705 45.12 US$122,043
2024-06-11 2024-06-11
PrS Proposed sale
1,823
31.50
US$57,424 		1,823 31.50 US$57,424
2024-06-11 2024-06-11
PlS Planned sale
1,823 -1.3%
31.34
US$57,133 		1,823 -1.3% 31.34 US$57,133
2024-05-17 2024-05-16
PlS Planned sale
495 -0.4%
28.59
US$14,152 		495 -0.4% 28.59 US$14,152
2024-05-17 2024-05-16
PlS Planned sale
2,279 -1.6%
28.20
US$64,268 		2,279 -1.6% 28.20 US$64,268
2024-05-16 2024-05-16
PrS Proposed sale
2,774
28.70
US$79,613 		2,774 28.70 US$79,613
2024-03-13 2024-03-11
PlS Planned sale
1,776 -1.3%
25.71
US$45,661 		1,776 -1.3% 25.71 US$45,661
2024-03-13 2024-03-11
S Sale
17,825 -11.2%
25.48
US$454,181 		17,825 -11.2% 25.48 US$454,181
2024-03-11 2024-03-11
PrS Proposed sale
19,601
25.16
US$493,161 		19,601 25.16 US$493,161
2024-03-13 2024-03-08
S Sale
689 -0.5%
27.31
US$18,817 		689 -0.5% 27.31 US$18,817
2024-03-13 2024-03-08
S Sale
54,648 -27.8%
26.72
US$1,460,195 		54,648 -27.8% 26.72 US$1,460,195
2024-03-13 2024-03-08
S Sale
34,663 -15.0%
25.46
US$882,520 		34,663 -15.0% 25.46 US$882,520
2024-03-08 2024-03-08
PrS Proposed sale
90,000
2.64
US$237,996 		90,000 2.64 US$237,996
2024-03-11 2024-03-07
PlS Planned sale
2,434 -1.7%
25.85
US$62,919 		2,434 -1.7% 25.85 US$62,919
2024-03-07 2024-03-07
PrS Proposed sale
2,434
25.85
US$62,921 		2,434 25.85 US$62,921
2024-03-01 2024-03-01
PrS Proposed sale
24,260
28.63
US$694,497 		24,260 28.63 US$694,497
2024-03-01 2024-03-01
PlS Planned sale
1,442 -1.0%
29.70
US$42,827 		1,442 -1.0% 29.70 US$42,827
2024-03-01 2024-03-01
PlS Planned sale
8,715 -5.7%
29.06
US$253,258 		8,715 -5.7% 29.06 US$253,258
2024-03-01 2024-03-01
PlS Planned sale
14,103 -8.4%
28.25
US$398,410 		14,103 -8.4% 28.25 US$398,410
2024-03-01 2024-02-29
PlS Planned sale
4,268 -2.9%
27.50
US$117,370 		4,268 -2.9% 27.50 US$117,370
2024-02-29 2024-02-29
PrS Proposed sale
4,268
27.50
US$117,382 		4,268 27.50 US$117,382
2024-01-26 2024-01-26
PrS Proposed sale
20,000
24.53
US$490,502 		20,000 24.53 US$490,502
2024-01-26 2024-01-26
PlS Planned sale
178 -0.1%
25.14
US$4,475 		178 -0.1% 25.14 US$4,475
2024-01-26 2024-01-26
PlS Planned sale
19,822 -12.1%
24.52
US$486,035 		19,822 -12.1% 24.52 US$486,035
2024-01-04 2024-01-04
PrS Proposed sale
2,009
18.04
US$36,246 		2,009 18.04 US$36,246
2024-01-04 2024-01-04
PlS Planned sale
2,009 -1.4%
18.04
US$36,242 		2,009 -1.4% 18.04 US$36,242
2024-01-04 2024-01-03
PlS Planned sale
10,300 -6.7%
19.03
US$196,009 		10,300 -6.7% 19.03 US$196,009
2024-01-04 2024-01-03
PlS Planned sale
7,691 -4.8%
18.34
US$141,053 		7,691 -4.8% 18.34 US$141,053
2024-01-03 2024-01-03
PrS Proposed sale
17,991
18.73
US$337,048 		17,991 18.73 US$337,048
2024-01-04 2024-01-02
PlS Planned sale
11,900 -7.7%
13.10
US$155,890 		11,900 -7.7% 13.10 US$155,890
2023-12-29 2024-01-02
PrS Proposed sale
11,900
13.30
US$158,270 		11,900 13.30 US$158,270
2023-12-12 2023-12-11
PlS Planned sale
1,245 -0.8%
10.72
US$13,346 		1,245 -0.8% 10.72 US$13,346
2023-09-20 2023-09-18
PlS Planned sale
1,261 -2.0%
9.41
US$11,866 		1,261 -2.0% 9.41 US$11,866
2023-09-13 2023-09-12
S Sale
1,266 -2.0%
10.41
US$13,179 		1,266 -2.0% 10.41 US$13,179
2023-06-14 2023-06-13
PlS Planned sale
1,259 -2.0%
12.43
US$15,649 		1,259 -2.0% 12.43 US$15,649